Article citationsMore>>

Abdul Latiff, Z., Azlin Kamal, N., Jahendran, J., Alias, H., See Goh, B., Zulkifli Syed Zakaria, S., et al. (2010) Vincristine-Induced Vocal Cord Palsy: Case Report and Review of the Literature. Journal Pediatric Hematology Oncology, 32, 407-410.
http://dx.doi.org/10.1097/MPH.0b013e3181e01584

has been cited by the following article:

• TITLE: Reversible Paclitaxel-Induced Bilateral Vocal Fold Paresis

  AUTHORS: Jeffrey Hsu, Melin Tan-Geller

  KEYWORDS: Vocal Cord Paralysis, Chemotherapy

  JOURNAL NAME: International Journal of Otolaryngology and Head & Neck Surgery, Vol.4 No.3, May 22, 2015

  ABSTRACT: Introduction: Chemotherapy is a rare cause of iatrogenic vocal fold dysfunction. It has been reported in three main classes of chemotherapy agents and often occurs during the treatment interval. We present a case of bilateral vocal cord paresis with delayed presentation after completion of chemotherapy. Methods: One case, managed with observation and serial exams, is presented. A review of previous case reports of chemotherapy-induced vocal cord paresis and possible mechanisms of injury was performed. Results: Patient improved both symptomatically and through objective findings over the one-year course of observation. Conclusion: Diagnosis of chemotherapy-induced vocal cord paresis is dependent on a thorough history and physical exam. Management is predicated in that the dysfunction is often dose dependent and reversible, necessitating both cessation of the offending agent and the knowledge that any treatment is likely needed for only a temporary time. Chemotherapy-induced vocal fold paresis should be in the differential for patients presenting with hoarseness, dysphonia, stridor and a positive chemotherapy history